The B12 is dissolved in the same solution and does not change the tirzepatide concentration listed on the label
Who AOD-9604 Is For and Who Should Avoid It AOD-9604 is a research compound
However, appetite reduction should still be paired with nutrition counseling
These include your current dose, how long youve been on the treatment, past nausea issues, how well you handle digestion, sugar level stability, and how semaglutide has worked for you so far
At Flow Wellness, our medical weight loss providers help patients understand their medication concentration and dosing instructions to ensure safe and accurate GLP-1 treatment
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses gradually titrated (starting at 2.5 mg weekly and increasing in 2.5 mg increments every 4 weeks as tolerated) to minimise gastrointestinal side effects